25 XP   0   0   10

Twist Bioscience Corp
Buy, Hold or Sell?

Let's analyse Twist Bioscience Corp together

PenkeI guess you are interested in Twist Bioscience Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Twist Bioscience Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Twist Bioscience Corp

I send you an email if I find something interesting about Twist Bioscience Corp.

Quick analysis of Twist Bioscience Corp (30 sec.)










What can you expect buying and holding a share of Twist Bioscience Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
14.8%

What is your share worth?

Current worth
$10.21
Expected worth in 1 year
$7.50
How sure are you?
37.0%

+ What do you gain per year?

Total Gains per Share
$-2.70
Return On Investment
-9.5%

For what price can you sell your share?

Current Price per Share
$28.36
Expected price per share
$25.78 - $42.08
How sure are you?
50%

1. Valuation of Twist Bioscience Corp (5 min.)




Live pricePrice per Share (EOD)

$28.36

Intrinsic Value Per Share

$-19.78 - $-22.48

Total Value Per Share

$-9.57 - $-12.27

2. Growth of Twist Bioscience Corp (5 min.)




Is Twist Bioscience Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$590m$804.9m-$161.1m-25.0%

How much money is Twist Bioscience Corp making?

Current yearPrevious yearGrowGrow %
Making money-$51.4m-$53.5m$2m4.0%
Net Profit Margin-79.4%-100.1%--

How much money comes from the company's main activities?

3. Financial Health of Twist Bioscience Corp (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#42 / 146

Most Revenue
#67 / 146

Most Profit
#134 / 146

Most Efficient
#102 / 146

What can you expect buying and holding a share of Twist Bioscience Corp? (5 min.)

Welcome investor! Twist Bioscience Corp's management wants to use your money to grow the business. In return you get a share of Twist Bioscience Corp.

What can you expect buying and holding a share of Twist Bioscience Corp?

First you should know what it really means to hold a share of Twist Bioscience Corp. And how you can make/lose money.

Speculation

The Price per Share of Twist Bioscience Corp is $28.36. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Twist Bioscience Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Twist Bioscience Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $10.21. Based on the TTM, the Book Value Change Per Share is $-0.68 per quarter. Based on the YOY, the Book Value Change Per Share is $0.52 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Twist Bioscience Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.74-2.6%-0.89-3.1%-0.93-3.3%-0.73-2.6%-0.64-2.2%
Usd Book Value Change Per Share-0.58-2.0%-0.68-2.4%0.521.8%0.391.4%0.381.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.642.3%0.481.7%
Usd Total Gains Per Share-0.58-2.0%-0.68-2.4%0.521.8%1.033.6%0.853.0%
Usd Price Per Share36.86-23.17-35.85-53.39-40.40-
Price to Earnings Ratio-12.39--6.89--9.58--20.60--15.81-
Price-to-Total Gains Ratio-63.83--36.06--33.10--63.54--60.33-
Price to Book Ratio3.61-2.13-2.55-7.14-5.65-
Price-to-Total Gains Ratio-63.83--36.06--33.10--63.54--60.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share28.36
Number of shares35
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.64
Usd Book Value Change Per Share-0.680.39
Usd Total Gains Per Share-0.681.03
Gains per Quarter (35 shares)-23.6536.11
Gains per Year (35 shares)-94.61144.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-95-1059055134
20-189-200180109278
30-284-295269164422
40-378-390359219566
50-473-485449273710
60-568-580539328854
70-662-675628383998
80-757-7707184371142
90-851-8658084921286
100-946-9608985471430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.026.00.03.7%1.026.00.03.7%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%6.014.00.030.0%9.016.02.033.3%9.016.02.033.3%
Dividend per Share0.00.04.00.0%3.00.09.025.0%4.00.016.020.0%4.00.023.014.8%4.00.023.014.8%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%7.013.00.035.0%10.015.02.037.0%10.015.02.037.0%

Fundamentals of Twist Bioscience Corp

About Twist Bioscience Corp

Twist Bioscience Corporation engages in the manufacture and sale of synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing, data storage in DNA, and other applications; and immunoglobulin G proteins for customers focused on the pursuit of drug discovery and development. It also provides NGS tools comprising library preparation kits, human exome kits, and fixed and custom panels, as well as alliance panels, primarily used within diagnostic tests for various indications, population genetics research and biomarker discovery, translational research, microbiology, and applied markets research; and methylation detection kits for cancer, and rare and inherited disease study, as well as fast hybridization and full RNA sequencing workflow solution. In addition, the company provides synthetic SARS-CoV-2 RNA reference sequences as positive controls for the development of both NGS and reverse transcription-polymerase chain reaction assays; synthetic monkeypox controls; and various respiratory viral controls, including for influenzas, respiratory syncytial virus, rhinoviruses, SARS, MERS, and coronaviruses. Further, it offers SARS-CoV-2 Research Panels, such as the Twist Respiratory Virus Panel and the Pan-Viral Research Panel, for the detection of disease in a research setting; precision DNA libraries used for antibody engineering, affinity maturation, and humanization; and antibody optimization solution to enable simultaneous optimization of multiple characteristics of a given antibody. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Fundamental data was last updated by Penke on 2024-04-12 20:48:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Twist Bioscience Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Twist Bioscience Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Twist Bioscience Corp to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -60.2% means that $-0.60 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Twist Bioscience Corp:

  • The MRQ is -60.2%. The company is making a huge loss. -2
  • The TTM is -79.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-60.2%TTM-79.4%+19.2%
TTM-79.4%YOY-100.1%+20.7%
TTM-79.4%5Y-129.0%+49.6%
5Y-129.0%10Y-236.3%+107.4%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-60.2%-7.2%-53.0%
TTM-79.4%-6.3%-73.1%
YOY-100.1%1.3%-101.4%
5Y-129.0%-2.2%-126.8%
10Y-236.3%-1.4%-234.9%
1.1.2. Return on Assets

Shows how efficient Twist Bioscience Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Twist Bioscience Corp to the Diagnostics & Research industry mean.
  • -5.9% Return on Assets means that Twist Bioscience Corp generated $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Twist Bioscience Corp:

  • The MRQ is -5.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.9%TTM-6.5%+0.6%
TTM-6.5%YOY-5.5%-1.0%
TTM-6.5%5Y-8.8%+2.3%
5Y-8.8%10Y-12.5%+3.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.9%-1.5%-4.4%
TTM-6.5%-1.2%-5.3%
YOY-5.5%-0.6%-4.9%
5Y-8.8%-0.6%-8.2%
10Y-12.5%-0.9%-11.6%
1.1.3. Return on Equity

Shows how efficient Twist Bioscience Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Twist Bioscience Corp to the Diagnostics & Research industry mean.
  • -7.3% Return on Equity means Twist Bioscience Corp generated $-0.07 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Twist Bioscience Corp:

  • The MRQ is -7.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.3%TTM-8.0%+0.7%
TTM-8.0%YOY-6.6%-1.3%
TTM-8.0%5Y-11.5%+3.6%
5Y-11.5%10Y-13.8%+2.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.3%-0.5%-6.8%
TTM-8.0%--8.0%
YOY-6.6%0.3%-6.9%
5Y-11.5%-1.5%-10.0%
10Y-13.8%-2.5%-11.3%

1.2. Operating Efficiency of Twist Bioscience Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Twist Bioscience Corp is operating .

  • Measures how much profit Twist Bioscience Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Twist Bioscience Corp to the Diagnostics & Research industry mean.
  • An Operating Margin of -60.0% means the company generated $-0.60  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Twist Bioscience Corp:

  • The MRQ is -60.0%. The company is operating very inefficient. -2
  • The TTM is -83.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-60.0%TTM-83.7%+23.7%
TTM-83.7%YOY-111.6%+28.0%
TTM-83.7%5Y-131.4%+47.7%
5Y-131.4%10Y-236.4%+105.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-60.0%-6.2%-53.8%
TTM-83.7%-5.8%-77.9%
YOY-111.6%4.8%-116.4%
5Y-131.4%1.6%-133.0%
10Y-236.4%-2.0%-234.4%
1.2.2. Operating Ratio

Measures how efficient Twist Bioscience Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.66 means that the operating costs are $1.66 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Twist Bioscience Corp:

  • The MRQ is 1.657. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.790. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.657TTM1.790-0.133
TTM1.790YOY2.116-0.326
TTM1.7905Y2.268-0.477
5Y2.26810Y3.456-1.189
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6571.310+0.347
TTM1.7901.303+0.487
YOY2.1161.240+0.876
5Y2.2681.270+0.998
10Y3.4561.228+2.228

1.3. Liquidity of Twist Bioscience Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Twist Bioscience Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 5.98 means the company has $5.98 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Twist Bioscience Corp:

  • The MRQ is 5.983. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.168. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.983TTM6.168-0.185
TTM6.168YOY6.907-0.739
TTM6.1685Y7.926-1.758
5Y7.92610Y7.078+0.848
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9832.194+3.789
TTM6.1682.366+3.802
YOY6.9072.753+4.154
5Y7.9262.989+4.937
10Y7.0783.000+4.078
1.3.2. Quick Ratio

Measures if Twist Bioscience Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Twist Bioscience Corp to the Diagnostics & Research industry mean.
  • A Quick Ratio of 6.00 means the company can pay off $6.00 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Twist Bioscience Corp:

  • The MRQ is 6.000. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.273. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.000TTM6.273-0.273
TTM6.273YOY7.888-1.615
TTM6.2735Y9.594-3.321
5Y9.59410Y8.365+1.229
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0001.273+4.727
TTM6.2731.355+4.918
YOY7.8881.563+6.325
5Y9.5941.952+7.642
10Y8.3652.127+6.238

1.4. Solvency of Twist Bioscience Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Twist Bioscience Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Twist Bioscience Corp to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.19 means that Twist Bioscience Corp assets are financed with 19.5% credit (debt) and the remaining percentage (100% - 19.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Twist Bioscience Corp:

  • The MRQ is 0.195. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.189. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.195TTM0.189+0.006
TTM0.189YOY0.169+0.020
TTM0.1895Y0.180+0.009
5Y0.18010Y0.542-0.362
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1950.425-0.230
TTM0.1890.411-0.222
YOY0.1690.393-0.224
5Y0.1800.450-0.270
10Y0.5420.448+0.094
1.4.2. Debt to Equity Ratio

Measures if Twist Bioscience Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Twist Bioscience Corp to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 24.2% means that company has $0.24 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Twist Bioscience Corp:

  • The MRQ is 0.242. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.233. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.242TTM0.233+0.009
TTM0.233YOY0.204+0.030
TTM0.2335Y0.2330.000
5Y0.23310Y0.343-0.110
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2420.606-0.364
TTM0.2330.571-0.338
YOY0.2040.606-0.402
5Y0.2330.637-0.404
10Y0.3430.730-0.387

2. Market Valuation of Twist Bioscience Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Twist Bioscience Corp generates.

  • Above 15 is considered overpriced but always compare Twist Bioscience Corp to the Diagnostics & Research industry mean.
  • A PE ratio of -12.39 means the investor is paying $-12.39 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Twist Bioscience Corp:

  • The EOD is -9.531. Based on the earnings, the company is expensive. -2
  • The MRQ is -12.388. Based on the earnings, the company is expensive. -2
  • The TTM is -6.890. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.531MRQ-12.388+2.857
MRQ-12.388TTM-6.890-5.499
TTM-6.890YOY-9.577+2.688
TTM-6.8905Y-20.603+13.713
5Y-20.60310Y-15.807-4.795
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-9.531-0.202-9.329
MRQ-12.388-0.402-11.986
TTM-6.890-0.119-6.771
YOY-9.577-0.003-9.574
5Y-20.6032.211-22.814
10Y-15.8074.907-20.714
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Twist Bioscience Corp:

  • The EOD is -16.746. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -21.765. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -12.281. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.746MRQ-21.765+5.019
MRQ-21.765TTM-12.281-9.485
TTM-12.281YOY-12.580+0.299
TTM-12.2815Y-22.867+10.587
5Y-22.86710Y-17.462-5.405
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-16.746-0.179-16.567
MRQ-21.765-0.417-21.348
TTM-12.281-1.288-10.993
YOY-12.580-2.547-10.033
5Y-22.867-1.999-20.868
10Y-17.462-2.372-15.090
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Twist Bioscience Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 3.61 means the investor is paying $3.61 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Twist Bioscience Corp:

  • The EOD is 2.779. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.612. Based on the equity, the company is fair priced.
  • The TTM is 2.132. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.779MRQ3.612-0.833
MRQ3.612TTM2.132+1.480
TTM2.132YOY2.549-0.417
TTM2.1325Y7.143-5.011
5Y7.14310Y5.648+1.495
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD2.7791.877+0.902
MRQ3.6122.437+1.175
TTM2.1322.235-0.103
YOY2.5493.239-0.690
5Y7.1433.450+3.693
10Y5.6484.040+1.608
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Twist Bioscience Corp.

3.1. Institutions holding Twist Bioscience Corp

Institutions are holding 113.083% of the shares of Twist Bioscience Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31ARK Investment Management LLC12.47581.574172132574272746.2964
2023-12-31BlackRock Inc10.28650.00565947453-132806-2.1842
2023-12-31Vanguard Group Inc9.46990.00445475322-115652-2.0685
2023-12-31JPMorgan Chase & Co7.98380.01644616073-451574-8.9109
2023-12-31Artisan Partners Limited Partnership6.43970.211337233051961621111.3492
2023-12-31Nikko Asset Management Americas Inc6.19781.26733583443995112.8563
2023-12-31Sumitomo Mitsui Trust Holdings Inc6.19780.09773583443995112.8563
2023-12-31William Blair Investment Management, LLC6.13970.38083549874-23549-0.659
2023-12-31State Street Corporation5.81520.0063362215-637766-15.9442
2023-12-31Millennium Management LLC3.14990.0291821238-1993372-52.2562
2023-12-31Amvescap Plc.2.93210.01491695311864305104.0071
2023-09-30Citadel Advisors Llc2.69540.00681558451-6276-0.4011
2023-12-31Goldman Sachs Group Inc2.53740.0049146709255414160.6978
2023-12-31Credit Suisse First Boston (CSFB)2.46210.05061423534-152796-9.6931
2023-12-31Bank of New York Mellon Corp2.45520.0106141952921742018.0865
2023-12-31Geode Capital Management, LLC2.2130.00491279493512974.1766
2023-12-31Dimensional Fund Advisors, Inc.2.19260.0137126770828488428.9863
2023-12-31Morgan Stanley - Brokerage Accounts1.97250.00371140460227232.0329
2023-12-31Baillie Gifford & Co Limited.1.89350.0321094758-173537-13.6827
2023-12-31Tao Capital Management LP1.433527.948282881500
Total 96.943431.682956050774+895359+1.6%

3.2. Funds holding Twist Bioscience Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31ARK Disruptive Innovation Full Composite6.55791.67543791676488241.3045
2024-03-28ARK Innovation ETF6.41361.6367370823370520.1905
2024-03-31ARK Genomic Revolution4.79935.9242774879-334440-10.7561
2024-03-28ARK Genomic Revolution ETF4.75085.8825274682355940.2041
2024-03-28SPDR® S&P Biotech ETF3.51730.9242033605256401.2769
2024-02-29Nikko AM ARK Disruptive Innovation A USD2.98782.1937172748000
2024-02-29Vanguard Total Stock Mkt Idx Inv2.97080.00441717685-5621-0.3262
2024-02-29Nikko AM ARK Pstv Chg Innovt P JPY Acc2.60972.3526150887500
2024-03-28iShares Russell 2000 ETF2.45270.074314181046840.0483
2024-02-29Vanguard Small Cap Index2.44260.03951412241130660.9338
2024-02-29CS (Lux) Digital Health Equity SB USD2.33493.4055135000000
2024-02-29JPMorgan Small Cap Growth A1.97421.10761141467-1048-0.0917
2024-02-29JPM Global Healthcare C (acc) USD1.84830.92081068632-140482-11.6186
2023-12-31Artisan U.S. Small-Cap Growth1.62282.04519382883660.039
2023-12-31Artisan Small Cap Investor1.62282.05529382883660.039
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.46370.03268462846160.0728
2024-02-29Vanguard Small Cap Growth Index Inv1.37090.0892792628131401.6857
2024-02-29BNY Mellon Sm/Md Cp Gr I1.26061.3492728830-23840-3.1674
2023-12-31Artisan Mid Cap Investor1.08880.48946295176295170
2023-12-31Artisan U.S. Mid-Cap Growth1.08880.48896295176295170
Total 55.178332.690631903052+868951+2.7%

3.3. Insider Transactions

Insiders are holding 1.789% of the shares of Twist Bioscience Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-09Adam LaponisSELL55633.16
2024-04-02Emily M LeproustSELL113232.74
2024-04-02Patrick John FinnSELL49232.74
2024-04-02Paula GreenSELL22932.74
2024-04-02William BanyaiSELL32732.74
2024-03-20Dennis ChoSELL23033.52
2024-03-20Emily M LeproustSELL112833.52
2024-03-20Paula GreenSELL20033.52
2024-03-14Dennis ChoSELL9334.6
2024-03-06Dennis ChoSELL27237.43
2024-03-06Emily M LeproustSELL148737.43
2024-03-06Paula GreenSELL60037.43
2024-03-06Robert F WernerSELL18137.43
2024-02-08Robert ChessSELL411034.98
2023-05-10Dennis ChoBUY1000013.2

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Twist Bioscience Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.578-0.676+17%0.520-211%0.390-248%0.378-253%
Book Value Per Share--10.20511.134-8%13.922-27%8.959+14%6.439+58%
Current Ratio--5.9836.168-3%6.907-13%7.926-25%7.078-15%
Debt To Asset Ratio--0.1950.189+3%0.169+15%0.180+8%0.542-64%
Debt To Equity Ratio--0.2420.233+4%0.204+19%0.233+4%0.343-30%
Dividend Per Share----0%-0%0.641-100%0.475-100%
Eps---0.744-0.890+20%-0.926+24%-0.729-2%-0.635-15%
Free Cash Flow Per Share---0.423-0.557+32%-1.006+138%-0.684+62%-0.605+43%
Free Cash Flow To Equity Per Share---0.449-0.558+24%0.166-370%0.170-364%0.177-353%
Gross Profit Margin--1.0001.0000%1.012-1%1.114-10%1.085-8%
Intrinsic Value_10Y_max---22.480--------
Intrinsic Value_10Y_min---19.776--------
Intrinsic Value_1Y_max---2.952--------
Intrinsic Value_1Y_min---2.900--------
Intrinsic Value_3Y_max---8.336--------
Intrinsic Value_3Y_min---7.969--------
Intrinsic Value_5Y_max---13.078--------
Intrinsic Value_5Y_min---12.185--------
Market Cap1639718480.000-30%2131171480.0001339353970.000+59%2072630755.000+3%3086700657.000-31%2335890028.148-9%
Net Profit Margin---0.602-0.794+32%-1.001+66%-1.290+114%-2.363+293%
Operating Margin---0.600-0.837+39%-1.116+86%-1.314+119%-2.364+294%
Operating Ratio--1.6571.790-7%2.116-22%2.268-27%3.456-52%
Pb Ratio2.779-30%3.6122.132+69%2.549+42%7.143-49%5.648-36%
Pe Ratio-9.531+23%-12.388-6.890-44%-9.577-23%-20.603+66%-15.807+28%
Price Per Share28.360-30%36.86023.165+59%35.848+3%53.387-31%40.401-9%
Price To Free Cash Flow Ratio-16.746+23%-21.765-12.281-44%-12.580-42%-22.867+5%-17.462-20%
Price To Total Gains Ratio-49.108+23%-63.827-36.058-44%-33.100-48%-63.5420%-60.329-5%
Quick Ratio--6.0006.273-4%7.888-24%9.594-37%8.365-28%
Return On Assets---0.059-0.065+10%-0.055-6%-0.088+50%-0.125+113%
Return On Equity---0.073-0.080+9%-0.066-9%-0.115+58%-0.138+89%
Total Gains Per Share---0.578-0.676+17%0.520-211%1.032-156%0.853-168%
Usd Book Value--590042000.000643739000.000-8%804937000.000-27%518017000.000+14%372271185.185+58%
Usd Book Value Change Per Share---0.578-0.676+17%0.520-211%0.390-248%0.378-253%
Usd Book Value Per Share--10.20511.134-8%13.922-27%8.959+14%6.439+58%
Usd Dividend Per Share----0%-0%0.641-100%0.475-100%
Usd Eps---0.744-0.890+20%-0.926+24%-0.729-2%-0.635-15%
Usd Free Cash Flow---24479000.000-32209500.000+32%-58175000.000+138%-39574500.000+62%-34976296.296+43%
Usd Free Cash Flow Per Share---0.423-0.557+32%-1.006+138%-0.684+62%-0.605+43%
Usd Free Cash Flow To Equity Per Share---0.449-0.558+24%0.166-370%0.170-364%0.177-353%
Usd Market Cap1639718480.000-30%2131171480.0001339353970.000+59%2072630755.000+3%3086700657.000-31%2335890028.148-9%
Usd Price Per Share28.360-30%36.86023.165+59%35.848+3%53.387-31%40.401-9%
Usd Profit---43008000.000-51450500.000+20%-53531000.000+24%-42127300.000-2%-36945111.111-14%
Usd Revenue--71498000.00065591000.000+9%53947250.000+33%39274900.000+82%30672296.296+133%
Usd Total Gains Per Share---0.578-0.676+17%0.520-211%1.032-156%0.853-168%
 EOD+3 -5MRQTTM+23 -10YOY+15 -195Y+14 -2210Y+17 -19

4.2. Fundamental Score

Let's check the fundamental score of Twist Bioscience Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.531
Price to Book Ratio (EOD)Between0-12.779
Net Profit Margin (MRQ)Greater than0-0.602
Operating Margin (MRQ)Greater than0-0.600
Quick Ratio (MRQ)Greater than16.000
Current Ratio (MRQ)Greater than15.983
Debt to Asset Ratio (MRQ)Less than10.195
Debt to Equity Ratio (MRQ)Less than10.242
Return on Equity (MRQ)Greater than0.15-0.073
Return on Assets (MRQ)Greater than0.05-0.059
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Twist Bioscience Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.293
Ma 20Greater thanMa 5032.468
Ma 50Greater thanMa 10035.614
Ma 100Greater thanMa 20034.092
OpenGreater thanClose28.270
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets732,815
Total Liabilities142,773
Total Stockholder Equity590,042
 As reported
Total Liabilities 142,773
Total Stockholder Equity+ 590,042
Total Assets = 732,815

Assets

Total Assets732,815
Total Current Assets390,231
Long-term Assets342,584
Total Current Assets
Cash And Cash Equivalents 266,269
Short-term Investments 44,875
Net Receivables 35,354
Inventory 30,863
Other Current Assets 12,870
Total Current Assets  (as reported)390,231
Total Current Assets  (calculated)390,231
+/-0
Long-term Assets
Property Plant Equipment 195,318
Goodwill 85,811
Intangible Assets 53,190
Long-term Assets Other 8,265
Long-term Assets  (as reported)342,584
Long-term Assets  (calculated)342,584
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities65,228
Long-term Liabilities77,545
Total Stockholder Equity590,042
Total Current Liabilities
Short-term Debt 14,808
Accounts payable 9,256
Other Current Liabilities 38,520
Total Current Liabilities  (as reported)65,228
Total Current Liabilities  (calculated)62,584
+/- 2,644
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt77,070
Long-term Liabilities Other 475
Long-term Liabilities  (as reported)77,545
Long-term Liabilities  (calculated)77,545
+/-0
Total Stockholder Equity
Retained Earnings -1,076,190
Accumulated Other Comprehensive Income -565
Other Stockholders Equity 1,666,797
Total Stockholder Equity (as reported)590,042
Total Stockholder Equity (calculated)590,042
+/-0
Other
Cash and Short Term Investments 311,144
Common Stock Shares Outstanding 57,497
Current Deferred Revenue2,644
Liabilities and Stockholders Equity 732,815
Net Debt -174,391
Net Invested Capital 590,042
Net Working Capital 325,003
Property Plant and Equipment Gross 252,924
Short Long Term Debt Total 91,878



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302016-09-30
> Total Assets 
76,463
85,657
0
0
122,665
115,791
164,453
140,170
206,805
186,994
192,277
323,872
408,240
398,882
699,570
677,289
725,298
702,097
786,167
1,021,636
979,663
961,378
909,970
853,924
810,332
776,403
732,815
732,815776,403810,332853,924909,970961,378979,6631,021,636786,167702,097725,298677,289699,570398,882408,240323,872192,277186,994206,805140,170164,453115,791122,6650085,65776,463
   > Total Current Assets 
59,039
67,869
0
0
103,776
95,671
146,663
120,991
182,622
160,135
129,288
260,205
344,578
334,870
634,428
607,999
576,607
546,495
385,007
664,375
624,117
596,483
541,859
489,271
445,537
424,256
390,231
390,231424,256445,537489,271541,859596,483624,117664,375385,007546,495576,607607,999634,428334,870344,578260,205129,288160,135182,622120,991146,66395,671103,7760067,86959,039
       Cash And Cash Equivalents 
28,596
31,227
0
0
90,900
80,757
66,459
28,693
68,212
46,735
26,032
184,395
207,853
93,667
348,789
399,329
475,279
465,829
191,624
407,627
376,249
378,687
316,681
315,196
307,459
286,470
266,269
266,269286,470307,459315,196316,681378,687376,249407,627191,624465,829475,279399,329348,78993,667207,853184,39526,03246,73568,21228,69366,45980,75790,9000031,22728,596
       Short-term Investments 
27,324
30,977
0
0
1,599
0
63,707
75,631
93,575
91,372
77,075
45,669
103,906
196,335
238,496
156,329
44,129
12,034
110,235
166,231
151,342
126,281
122,029
72,462
49,686
49,943
44,875
44,87549,94349,68672,462122,029126,281151,342166,231110,23512,03444,129156,329238,496196,335103,90645,66977,07591,37293,57575,63163,70701,5990030,97727,324
       Net Receivables 
723
2,346
0
0
4,289
5,419
6,978
7,998
11,697
12,104
13,054
14,831
13,347
26,376
25,492
27,290
28,116
28,549
32,872
34,877
41,195
40,294
44,437
48,187
42,580
44,064
35,354
35,35444,06442,58048,18744,43740,29441,19534,87732,87228,54928,11627,29025,49226,37613,34714,83113,05412,10411,6977,9986,9785,4194,289002,346723
       Inventory 
1,228
1,827
0
0
4,253
6,028
5,561
4,449
5,496
7,330
7,416
10,764
13,161
12,289
13,409
15,838
21,224
31,800
40,239
44,591
43,022
39,307
44,597
39,923
36,354
32,063
30,863
30,86332,06336,35439,92344,59739,30743,02244,59140,23931,80021,22415,83813,40912,28913,16110,7647,4167,3305,4964,4495,5616,0284,253001,8271,228
       Other Current Assets 
1,168
1,492
0
0
2,735
3,467
3,958
4,220
3,642
2,594
5,711
4,546
6,311
6,203
8,242
9,213
7,859
8,283
10,037
11,049
12,309
11,914
14,115
13,503
9,458
11,716
12,870
12,87011,7169,45813,50314,11511,91412,30911,04910,0378,2837,8599,2138,2426,2036,3114,5465,7112,5943,6424,2203,9583,4672,735001,4921,168
   > Long-term Assets 
0
17,788
0
0
18,889
20,120
17,790
19,179
24,183
26,859
62,989
63,667
63,662
64,012
65,142
69,290
148,691
155,602
401,160
357,261
355,546
364,895
368,111
364,653
364,795
352,147
342,584
342,584352,147364,795364,653368,111364,895355,546357,261401,160155,602148,69169,29065,14264,01263,66263,66762,98926,85924,18319,17917,79020,12018,8890017,7880
       Property Plant Equipment 
14,617
14,834
0
0
12,760
12,331
13,596
14,940
19,817
20,835
58,577
59,119
58,934
59,165
59,483
62,972
100,667
105,702
137,155
170,029
203,176
214,389
218,607
217,208
212,806
203,361
195,318
195,318203,361212,806217,208218,607214,389203,176170,029137,155105,702100,66762,97259,48359,16558,93459,11958,57720,83519,81714,94013,59612,33112,7600014,83414,617
       Goodwill 
1,138
1,138
0
0
1,138
1,138
1,138
1,138
1,138
1,138
1,138
1,138
1,138
1,138
1,138
1,138
22,676
22,434
84,244
85,678
85,811
85,811
85,811
85,811
85,811
85,811
85,811
85,81185,81185,81185,81185,81185,81185,81185,67884,24422,43422,6761,1381,1381,1381,1381,1381,1381,1381,1381,1381,1381,1381,138001,1381,138
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
106,843
30,587
0
0
0
0
0
0
0
000000030,587106,843000000000000000000
       Intangible Assets 
2,271
920
0
0
763
712
661
610
559
508
458
407
356
307
256
203
18,562
18,262
63,921
62,493
61,115
59,738
58,361
57,068
55,775
54,483
53,190
53,19054,48355,77557,06858,36159,73861,11562,49363,92118,26218,562203256307356407458508559610661712763009202,271
       Long-term Assets Other 
0
896
0
0
4,228
5,939
2,395
2,491
2,669
4,378
2,816
3,003
3,234
3,402
4,265
4,977
6,786
9,204
8,997
8,474
5,444
4,957
5,332
4,566
10,403
8,492
8,265
8,2658,49210,4034,5665,3324,9575,4448,4748,9979,2046,7864,9774,2653,4023,2343,0032,8164,3782,6692,4912,3955,9394,228008960
> Total Liabilities 
19,037
219,015
0
0
26,209
317,213
25,857
24,690
30,802
34,912
89,196
59,670
59,294
62,620
61,618
63,108
114,850
121,276
159,989
158,275
158,986
171,993
163,645
149,992
152,782
152,971
142,773
142,773152,971152,782149,992163,645171,993158,986158,275159,989121,276114,85063,10861,61862,62059,29459,67089,19634,91230,80224,69025,857317,21326,20900219,01519,037
   > Total Current Liabilities 
8,678
9,477
0
0
18,088
18,537
18,998
18,580
25,447
30,354
57,844
30,210
31,377
36,029
37,102
40,442
54,833
63,052
80,034
84,632
92,686
90,663
83,837
72,108
72,822
73,323
65,228
65,22873,32372,82272,10883,83790,66392,68684,63280,03463,05254,83340,44237,10236,02931,37730,21057,84430,35425,44718,58018,99818,53718,088009,4778,678
       Short-term Debt 
1,367
9,154
0
0
1,667
2,500
3,333
3,333
3,333
3,333
11,704
11,110
10,002
9,742
9,777
9,682
9,910
9,765
12,684
14,166
14,352
13,642
14,227
13,396
13,132
14,896
14,808
14,80814,89613,13213,39614,22713,64214,35214,16612,6849,7659,9109,6829,7779,74210,00211,11011,7043,3333,3333,3333,3332,5001,667009,1541,367
       Short Long Term Debt 
1,367
9,154
0
0
1,667
2,500
3,333
3,333
3,333
3,333
3,333
3,333
3,333
3,333
3,333
3,168
7,545
1,552
0
0
0
0
0
0
0
0
0
0000000001,5527,5453,1683,3333,3333,3333,3333,3333,3333,3333,3333,3332,5001,667009,1541,367
       Accounts payable 
2,337
2,849
0
0
4,502
7,531
6,725
4,505
7,835
9,760
9,106
6,932
5,973
4,830
8,932
8,528
11,268
14,900
23,073
16,815
21,014
20,092
20,113
13,236
12,184
14,052
9,256
9,25614,05212,18413,23620,11320,09221,01416,81523,07314,90011,2688,5288,9324,8305,9736,9329,1069,7607,8354,5056,7257,5314,502002,8492,337
       Other Current Liabilities 
4,974
6,628
0
0
5,930
939
1,073
894
680
817
999
52
1,373
2,611
3,306
4,063
9,265
9,623
13,856
53,651
57,320
53,453
45,814
43,532
9,911
7,803
38,520
38,5207,8039,91143,53245,81453,45357,32053,65113,8569,6239,2654,0633,3062,6111,373529998176808941,0739395,930006,6284,974
   > Long-term Liabilities 
0
209,538
0
0
8,121
298,676
6,859
6,110
5,355
4,558
31,352
29,460
27,917
26,591
24,516
22,666
60,017
58,224
79,955
73,643
66,300
81,330
79,808
77,884
79,960
79,648
77,545
77,54579,64879,96077,88479,80881,33066,30073,64379,95558,22460,01722,66624,51626,59127,91729,46031,3524,5585,3556,1106,859298,6768,12100209,5380
       Long term Debt Total 
0
0
0
0
0
0
6,526
5,828
5,119
4,400
3,669
2,925
0
1,403
625
0
0
0
0
0
0
0
0
0
0
0
0
0000000000006251,40302,9253,6694,4005,1195,8286,526000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
35,910
34,217
32,416
31,246
30,125
28,758
56,214
61,369
72,969
79,662
78,596
94,912
93,975
91,220
93,032
94,069
91,878
91,87894,06993,03291,22093,97594,91278,59679,66272,96961,36956,21428,75830,12531,24632,41634,21735,9100000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
333
282
236
158
144
95
0
25,188
23,891
22,666
6,168
58,224
19,670
73,643
2,056
60
60
60
60
475
475
475475606060602,05673,64319,67058,2246,16822,66623,89125,188095144158236282333000000
       Deferred Long Term Liability 
0
0
0
0
2,400
3,700
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000003,7002,4000000
> Total Stockholder Equity
57,426
-133,358
-133,358
0
96,456
-201,422
138,596
115,480
176,003
152,082
103,081
264,202
348,946
336,262
637,952
614,181
610,448
580,821
626,178
863,361
820,677
789,385
746,325
703,932
657,550
623,432
590,042
590,042623,432657,550703,932746,325789,385820,677863,361626,178580,821610,448614,181637,952336,262348,946264,202103,081152,082176,003115,480138,596-201,42296,4560-133,358-133,35857,426
   Common Stock
0
0
0
0
0
0
-164,453
115,480
-206,805
152,082
0
264,202
348,946
336,262
637,952
614,181
610,448
580,821
626,178
0
820,677
789,385
0
0
0
0
0
00000789,385820,6770626,178580,821610,448614,181637,952336,262348,946264,2020152,082-206,805115,480-164,453000000
   Retained Earnings Total Equity00-986,791-929,396-870,240-828,416-777,301-716,784-656,116-610,553-569,311-529,274-491,355-458,455-434,137-405,930-374,162-318,524-287,343-259,427-233,494000000
   Accumulated Other Comprehensive Income 
0
33
0
0
68
87
24
-136
117
181
190
213
134
87
142
190
428
546
363
-475
-1,377
-1,843
-609
111
-635
-756
-565
-565-756-635111-609-1,843-1,377-47536354642819014287134213190181117-13624876800330
   Capital Surplus 
0
0
0
0
0
0
372,066
375,043
463,229
470,425
477,053
669,919
782,949
794,630
1,129,165
1,143,265
1,179,331
1,190,828
1,281,931
1,580,620
1,599,355
1,619,644
1,617,174
1,633,217
1,644,976
0
0
001,644,9761,633,2171,617,1741,619,6441,599,3551,580,6201,281,9311,190,8281,179,3311,143,2651,129,165794,630782,949669,919477,053470,425463,229375,043372,066000000
   Treasury Stock000000000000000000000000000
   Other Stockholders Equity 
9
6,228
0
0
287,441
9,346
372,066
375,043
463,229
470,425
477,053
669,919
782,949
794,630
1,129,165
1,143,265
1,179,331
1,190,828
1,281,931
1,580,620
1,599,355
1,619,644
1,617,174
1,633,217
1,644,976
1,657,222
1,666,797
1,666,7971,657,2221,644,9761,633,2171,617,1741,619,6441,599,3551,580,6201,281,9311,190,8281,179,3311,143,2651,129,165794,630782,949669,919477,053470,425463,229375,043372,0669,346287,441006,2289



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue245,109
Cost of Revenue-155,380
Gross Profit89,72989,729
 
Operating Income (+$)
Gross Profit89,729
Operating Expense-296,632
Operating Income-217,159-206,903
 
Operating Expense (+$)
Research Development106,894
Selling General Administrative189,738
Selling And Marketing Expenses0
Operating Expense296,632296,632
 
Net Interest Income (+$)
Interest Income14,365
Interest Expense-5
Other Finance Cost-0
Net Interest Income14,360
 
Pretax Income (+$)
Operating Income-217,159
Net Interest Income14,360
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-203,466-206,236
EBIT - interestExpense = -217,164
-203,466
-204,613
Interest Expense5
Earnings Before Interest and Taxes (EBIT)-217,159-203,461
Earnings Before Interest and Taxes (EBITDA)-193,205
 
After tax Income (+$)
Income Before Tax-203,466
Tax Provision-1,152
Net Income From Continuing Ops-204,618-204,618
Net Income-204,618
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses452,012
Total Other Income/Expenses Net-10,923-14,360
 

Technical Analysis of Twist Bioscience Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Twist Bioscience Corp. The general trend of Twist Bioscience Corp is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Twist Bioscience Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Twist Bioscience Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 36.92 < 41.45 < 42.08.

The bearish price targets are: 27.36 > 27.09 > 25.78.

Tweet this
Twist Bioscience Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Twist Bioscience Corp. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Twist Bioscience Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Twist Bioscience Corp. The current macd is -1.79595598.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Twist Bioscience Corp price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Twist Bioscience Corp. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Twist Bioscience Corp price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Twist Bioscience Corp Daily Moving Average Convergence/Divergence (MACD) ChartTwist Bioscience Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Twist Bioscience Corp. The current adx is 18.83.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Twist Bioscience Corp shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Twist Bioscience Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Twist Bioscience Corp. The current sar is 31.60.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Twist Bioscience Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Twist Bioscience Corp. The current rsi is 30.29. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Twist Bioscience Corp Daily Relative Strength Index (RSI) ChartTwist Bioscience Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Twist Bioscience Corp. The current phase is Oversold in neutral market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Twist Bioscience Corp price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Twist Bioscience Corp Daily Stochastic Oscillator ChartTwist Bioscience Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Twist Bioscience Corp. The current cci is -157.01470528.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Twist Bioscience Corp Daily Commodity Channel Index (CCI) ChartTwist Bioscience Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Twist Bioscience Corp. The current cmo is -49.91618242.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Twist Bioscience Corp Daily Chande Momentum Oscillator (CMO) ChartTwist Bioscience Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Twist Bioscience Corp. The current willr is -92.46987952.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Twist Bioscience Corp Daily Williams %R ChartTwist Bioscience Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Twist Bioscience Corp.

Twist Bioscience Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Twist Bioscience Corp. The current atr is 1.72809259.

Twist Bioscience Corp Daily Average True Range (ATR) ChartTwist Bioscience Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Twist Bioscience Corp. The current obv is -16,256,389.

Twist Bioscience Corp Daily On-Balance Volume (OBV) ChartTwist Bioscience Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Twist Bioscience Corp. The current mfi is 30.50.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Twist Bioscience Corp Daily Money Flow Index (MFI) ChartTwist Bioscience Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Twist Bioscience Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-30STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Twist Bioscience Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Twist Bioscience Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.293
Ma 20Greater thanMa 5032.468
Ma 50Greater thanMa 10035.614
Ma 100Greater thanMa 20034.092
OpenGreater thanClose28.270
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Twist Bioscience Corp with someone you think should read this too:
  • Are you bullish or bearish on Twist Bioscience Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Twist Bioscience Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Twist Bioscience Corp

I send you an email if I find something interesting about Twist Bioscience Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Twist Bioscience Corp.

Receive notifications about Twist Bioscience Corp in your mailbox!